Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5278]

$FDA approves duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma$

FDA approves duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukaemia or small...

NELSON study shows CT screening for nodule volume management reduces lung cancer mortality by 26% in men

NELSON study shows CT screening for nodule volume management reduces lung cancer mortality by 26% in men

Poziotinib maintains high response rate against harmful lung cancer mutation

Poziotinib maintains high response rate against harmful lung cancer mutation

Durvalumab improves OS in PACIFIC trial for unresectable NSCLC after chemoradiotherapy

Durvalumab improves OS in PACIFIC trial for unresectable NSCLC after chemoradiotherapy

Atezolizumab combination improves PFS for advanced NSCLC patients

Atezolizumab combination improves PFS for advanced NSCLC patients

Cancer cells evade immunotherapy by hiding telltale marker

Cancer cells evade immunotherapy by hiding telltale marker

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated with crizotinib

CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated...

Eight of 10 people with cancer risk genes don't know it

Eight of 10 people with cancer risk genes don't know it

DNA vaccine leads to immune responses in HPV-related head and neck cancer

DNA vaccine leads to immune responses in HPV-related head and neck cancer

More from ecancer